Intra-Hepatic Cholangiocarcinoma: New Treatment Approaches

We are studying a combination of treatments for patients with inoperable intra-hepatic cholangiocarcinoma. The goal is to see if these treatments can improve survival and quality of life.

>2 years 11-15 visits Monitoring phase (IV)No Placebo Investigational Medicines InjectionInternal MedicineOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Heparin

Heparin is a medicine used to prevent and treat blood clots.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Dexamethasone Sodium Phosphate

Dexamethasone sodium phosphate is a corticosteroid substance that reduces inflammation and suppresses the immune response.

Gemcitabine Hydrochloride

Gemcitabine hydrochloride is a chemotherapy substance used to treat several types of cancer by interfering with cancer cell growth and division.

Heparin

Heparin is a substance that helps prevent and treat blood clots.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Floxuridine

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Aescin

Allé

Alle Forte

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Oslo University Hospital HF

Gastrokirurgisk avdeling, Rikshospitalet

Oslo, Norway

Sponsor: Oslo University Hospital HF

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.